This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Alopecia Treatment Market

Hair fall emerges as prime concern in emerging countries, escalating Alopecia Treatment market: Opportunities ahead

Alopecia Treatment Market by Disease Type, Treatment Type, Gender Type, Sales Type & Region – Forecast 2022–2032

Alopecia Treatment Market Outlook

Newly-released Alopecia Treatment Market analysis report by Future Market Insight shows that global sales of the Alopecia Treatment Market in 2021 was held at US$ 8.4 Bn. With a CAGR of 9.5% during 2022 - 2032, the market is projected to reach a valuation of US$ 22.5 Bn by 2032. The market through Alopecia Areata is expected to gross significant revenue, accounting for an expected CAGR rate of 9.5% during 2022 – 2032.

Attribute

Details

Global Alopecia Treatment Market (2022)

US$ 9.1 Bn

Global Alopecia Treatment Market (2032)

US$ 22.5 Bn

Global Alopecia Treatment Market CAGR (2022 – 2032)

9.5%

U.S. Alopecia Treatment Market (2022)

US$ 2.8 Bn

Key Companies Profiled

  • iRestore Hair Growth System
  • iGrow Laser
  • Thera dome
  • Curallux
  • Lexington Intl., LLC.
  • LUTRONIC
Customize this Report

Let us know your requirement to get
100% FREE customization

Revenue of Alopecia Treatment Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the Alopecia Treatment Market research by Future Market Insight - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Alopecia Treatment Market increased at around 8.5% CAGR.

Demand for hair-restoration drugs, which often have improved efficacy and minimal side effects, has led to the development of the market for alopecia treatment. For example, cutting-edge treatments including cytokine therapy and regenerative cell therapy are becoming increasingly popular within the field of alopecia treatment.

Hair regrowth is enhanced by cytokine therapy, which causes hair follicle cells to differentiate and proliferate while controlling the hair growth cycle. Combination therapies have also been shown to be clinically effective in the treatment of Alopecia Treatment. Combination therapeutics are currently the most widely used hair loss treatment.

Increased focus on providing hair loss solutions (with both functional and active ingredients) with multifunctional effects, as well as increased penetration of advanced hair loss treatment therapies such as stem cell therapy, are set to define the market landscape of the hair loss industry over the forecast period.

The introduction of low-level laser therapy, which helps stimulate hair growth, is expected to boost the number of patients treated for hair loss. Furthermore, the introduction of laser caps, helmets, combs, and bands are expected to boost the market growth. Some of the technologically advanced products on the market include the Capillus Laser Cap, iGrow Laser Helmet, iRestore Hair Growth System, and Hairmax Laser devices.

How are the increasing initiatives and growing prevalence of Hair Loss fuelling the Alopecia Treatment Market?

An increase in healthcare spending is being driven by an increase in the number of initiatives being undertaken by organizations such as the National Alopecia Treatment Areata Foundation and the American Hair Loss Association to raise awareness about hair regrowth and treatment options.

The Affordable Care Act of 2010 allows people to purchase health insurance at a low cost, thereby benefiting patients who are financially disadvantaged. This led to an overall increase in treatment rates, driving the market growth. Furthermore, as people become more aware of hair loss, there is a greater demand for painless therapies with few side effects, which is driving up the treatment rate around the world.

The increase in the incidence of Alopecia Treatment is among the primary factors driving the market growth. In the United States in 2018, the American Academy of Dermatology Association (AAD) estimated that roughly Alopecia affected 50 million individuals and 30 million women, more than 50 million men, and 30 million women.

According to The Journal of Clinical and Diagnostic Research (JCDR)'s study, roughly 60% of the population suffers from hair loss, with various factors contributing to the severity of pattern hair loss in both sexes.

Furthermore, the prevalence of chronic diseases such as cancer, Polycystic Ovary Syndrome (PCOS), and rheumatoid arthritis, all of which are linked to the loss of hair, is expected to increase the demand for the treatment of hair loss in the near future. According to the Department of Health and Human Services of the United States, PCOS affects nearly 5 million individuals in the United States.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Region is projected to Offer the Largest Opportunity for Alopecia Treatment Market?

In 2021, North America was the largest market for Alopecia Treatment globally. It is because the country has an advanced healthcare infrastructure, a high disposable income, and a multitude of novel treatment options. Roughly one in 500 to 1,000 individuals are affected by alopecia areata in the United States, according to the National Library of Medicine. The second most common form of alopecia treatment after androgenic alopecia treatment is alopecia treatment areata, one of the most common kinds of alopecia treatment.

Country-wise Analysis

U.S. Alopecia Treatment Market Analysis

The United States is expected to account for the highest market share of US$ 7.3 Bn by the end of 2032. Alopecia areata is a common autoimmune condition that causes sporadic hair loss. In the United States, it affects approximately 6.8 million people. Furthermore, the region's advanced healthcare infrastructure, combined with strict Alopecia Treatment requirements, is expected to accelerate the advancement of the market in the country.

China Alopecia Treatment Market Analysis

China dominates the Asia Pacific market with a CAGR of 10.9% having an absolute dollar growth opportunity of US$ 1.9 Bn. As more consumers share the incidence of hair loss problems, cosmetic product manufacturers are introducing additional hair care products and drinks that target these individuals, leading to a rise in cosmetics spending in China.

The majority of consumers have consequently perceived the demand as well as the need for natural and organic products for personal hair care. Shampoo and conditioner accounted for the majority of the regional and global organic haircare market in 2019, owing to the massive use of these products.

In China, for instance, Henkel Beauty Care introduced the Schwarzkopf Extra Care Sun Repair Spray Conditioner in 2017, which boasts a highly effective formula combining Monoi Flower Extract and UVA/UVB filtering agents that repairs and protects hair from the sun and salt damage. Likewise, brand-endorsed hair care products, including conditioners, have gained immense popularity in China.

U.K. Alopecia Treatment Market Analysis

The market in the U.K. is projected to reach a valuation of US$ 974 Mn by 2032. Growing at a CAGR of 10.2%, the market in the country is projected to gross an absolute dollar opportunity of over US$ 600 Mn during 2022 – 2032.

Japan Alopecia Treatment Market Analysis

In Japan, the market is expected to reach US$ 1.2 Bn by 2032, growing at a CAGR of 11.1% during the forecast period. During this period, the market is likely to gross an absolute dollar opportunity of US$ 780 Mn.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Category-wise Insights

What are the insights about Alopecia Revenue through Treatment Type and Sales Channel?

In 2021, the pharmaceutical segment dominated the Alopecia Treatment type. The segment is driven by the low cost of pharmaceutical products and the high use of prescription and over-the-counter drugs. The most common drugs used to treat Alopecia Treatment are Finasteride and Minoxidil.

Finasteride and Minoxidil are the only drugs approved in the United States to treat both Female Pattern Hair Loss (FPHL) and Male Pattern Hair Loss (MPHL) (MPHL). Furthermore, key pharmaceutical companies such as Lilly, Pfizer Inc., and Concert Pharmaceuticals are actively involved in the development of novel Alopecia Treatments, which is expected to drive the market over the forecast period.

Due to the high number of visits to dermatologists for hair loss treatment, the prescription segment dominated the market and accounted for the largest revenue share in 2021. According to the National Library of Medicine, approximately 2.6 million outpatients seek Alopecia areata treatment from dermatologists in the United States each year. Furthermore, a strong product pipeline, rising disposable incomes, and an increase in the prevalence of chronic diseases that lead to hair loss are expected to propel the segment's growth at the fastest rate during the forecast period.

Which Gender Type Offers the Most Lucrative Opportunities for Alopecia Treatment?

Due to the high prevalence of hair loss in the male population worldwide, the market revenue through male Alopecia treatment dominated in 2021. The most common type of Alopecia Treatment in men is androgenetic Alopecia Treatment. A study cited that around 50% of men in their 50s will experience loss of hair, with androgenetic blading accounting for more than 95% of cases.

The female Alopecia Treatment market, on the other hand, is expected to grow at the fastest rate during the forecast period. The market is expected to grow due to rising awareness, lifestyle changes, increased PCOS levels, and a growing trend of cosmetic procedures.

Hair loss affects about one-third of women at some point in their lives. Hair thinning or bald spots affect up to two-thirds of postmenopausal women. Women's hair loss has a greater impact than men's hair loss because it is less socially acceptable for them. The most common cause of hair loss in women is androgenetic Alopecia Treatment. Alopecia Treatment can have a significant impact on a woman's emotional health and quality of life.

Competitive Analysis

iRestore Hair Growth System, iGrow Laser, Theradome, Curallux, LLC, and LUTRONIC are some of the leading players in the Alopecia treatment market. Players in the market are increasingly forming partnerships and licensing agreements to further refine their product lines and expand their operations. For instance, in China, the Central Pharmaceuticals Group partnered with the iGrow laser system.

China Central Pharmaceuticals has exclusive rights to Aspira in China, and Capillus, LLC has partnered with Svenson, a hair loss treatment clinic, to set up distribution rights for laser therapy caps in Europe, Asia-Pacific, and Australia. The expansion with business partners and local associates is anticipated to heighten the utilization of non-toxic hair removal technology.

Some of the recent developments of key Alopecia Treatment providers are as follows:

  • In Aug 2021, Pfizer Inc. announced the positive results of Phase 2b 3 ALLEGRO, which evaluated an oral once-a-day Ritlecitinib drug in patients with alopecia areata, an autoimmune disease characterized by the hair loss on the scalp and can also affect the face and body.
  • In March 2020, the U.S. Food and Drug Administration (FDA) granted Baricitinib Breakthrough Therapy designation for the treatment of Alopecia Treatment Areata (AA), an autoimmune disorder. The designation of Breakthrough Therapy aims to speed up the development and review of drugs that are intended to treat a serious condition.

Similarly, recent developments related to companies Alopecia Treatment Market have been tracked by the team at Future Market Insight, which are available in the full report.

Market Segments Covered in Alopecia Treatment Market Analysis

By Disease Type:

  • Alopecia Areata
  • Cicatricial Alopecia
  • Traction Alopecia
  • Alopecia Totalis
  • Androgenetic Alopecia
  • Alopecia Universalis
  • Other Disease Types

By Treatment Type:

  • Pharmaceuticals
  • Devices

By Gender:

  • Male
  • Female

By Sales Channel:

  • Prescriptions
  • OTC

By Region:

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Frequently Asked Questions

The global Alopecia Treatment Market is worth more than US$ 8.4 Bn at present.

The value of the Alopecia Treatment Market is projected to increase at a CAGR of around 9.5% during 2022 – 2032.

The value of the Alopecia Treatment Market increased at a CAGR of around 8.5% during 2017 – 2021.

Technological advancements, improved reimbursement scenarios, and rising healthcare expenditures around the world are all driving the Alopecia Treatment market forward.

The market of Alopecia Treatment Market in China is projected to expand at a CAGR of around 10.9 % during 2022 – 2032.

Both the UK and South Korea market is expected to grow at nearly 10.2% during 2022 - 2032.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage

    2.2. Market Definition

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Alopecia demands

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$Bn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background

    4.1. Market, by Key Countries

    4.2. Market Opportunity Assessment (US$Bn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Alopecia demands Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global Market Demand Analysis 2017-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2017-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Market Value Analysis 2017-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$Bn) Analysis, 2017-2021

    7.2. Current and Future Market Value (US$Bn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Disease Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$Bn) Analysis By Disease Type , 2017-2021

    8.3. Current and Future Market Size (US$Bn) Analysis and Forecast By Disease Type , 2022-2032

        8.3.1. Alopecia Areata

        8.3.2. Cicatricial Alopecia

        8.3.3. Traction Alopecia

        8.3.4. Alopecia Totalis

        8.3.5. Alopecia Universalis

        8.3.6. Androgenetic Alopecia

        8.3.7. Other Disease Types

    8.4. Market Attractiveness Analysis By Disease Type

9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Treatment Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$Bn) Analysis By Treatment Type , 2017-2021

    9.3. Current and Future Market Size (US$Bn) Analysis and Forecast By Treatment Type , 2022-2032

        9.3.1. Pharmaceuticals

        9.3.2. Devices

    9.4. Market Attractiveness Analysis By Treatment Type

10. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Gender

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$Bn) Analysis By Gender , 2017-2021

    10.3. Current and Future Market Size (US$Bn) Analysis and Forecast By Gender , 2022-2032

        10.3.1. Male

        10.3.2. Female

    10.4. Market Attractiveness Analysis By Gender

11. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Sales Channel

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$Bn) Analysis By Sales Channel , 2017-2021

    11.3. Current and Future Market Size (US$Bn) Analysis and Forecast By Sales Channel , 2022-2032

        11.3.1. Prescriptions

        11.3.2. OTC

    11.4. Market Attractiveness Analysis By Sales Channel

12. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    12.1. Introduction

    12.2. Historical Market Size (US$Bn) Analysis By Region, 2017-2021

    12.3. Current Market Size (US$Bn) & Analysis and Forecast By Region, 2022-2032

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. Asia Pacific

        12.3.5. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2017-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Value (US$Bn) Trend Analysis By Market Taxonomy, 2017-2021

    13.4. Market Value (US$Bn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. U.S.

            13.4.1.2. Canada

            13.4.1.3. Rest of North America

        13.4.2. By Disease Type

        13.4.3. By Treatment Type

        13.4.4. By Sales Channel

        13.4.5. By Gender

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Disease Type

        13.5.3. By Treatment Type

        13.5.4. By Sales Channel

        13.5.5. By Gender

14. Latin America Market Analysis 2017-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$Bn) Trend Analysis By Market Taxonomy, 2017-2021

    14.4. Market Value (US$Bn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. Brazil

            14.4.1.2. Mexico

            14.4.1.3. Rest of Latin America

        14.4.2. By Disease Type

        14.4.3. By Treatment Type

        14.4.4. By Sales Channel

        14.4.5. By Gender

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Disease Type

        14.5.3. By Treatment Type

        14.5.4. By Sales Channel

        14.5.5. By Gender

15. Europe Market Analysis 2017-2021 and Forecast 2022-2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Value (US$Bn) Trend Analysis By Market Taxonomy, 2017-2021

    15.4. Market Value (US$Bn) & Forecast By Market Taxonomy, 2022-2032

        15.4.1. By Country

            15.4.1.1. Germany

            15.4.1.2. France

            15.4.1.3. U.K.

            15.4.1.4. Italy

            15.4.1.5. Spain

            15.4.1.6. Russia

            15.4.1.7. Rest of Europe

        15.4.2. By Disease Type

        15.4.3. By Treatment Type

        15.4.4. By Sales Channel

        15.4.5. By Gender

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Disease Type

        15.5.3. By Treatment Type

        15.5.4. By Sales Channel

        15.5.5. By Gender

16. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Value (US$Bn) Trend Analysis By Market Taxonomy, 2017-2021

    16.4. Market Value (US$Bn) & Forecast By Market Taxonomy, 2022-2032

        16.4.1. By Country

            16.4.1.1. China

            16.4.1.2. Japan

            16.4.1.3. South Korea

            16.4.1.4. India

            16.4.1.5. Australia

            16.4.1.6. South Korea

            16.4.1.7. Rest of Asia Pacific

        16.4.2. By Disease Type

        16.4.3. By Treatment Type

        16.4.4. By Sales Channel

        16.4.5. By Gender

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Disease Type

        16.5.3. By Treatment Type

        16.5.4. By Sales Channel

        16.5.5. By Gender

17. Middle East and Africa Market Analysis 2017-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Value (US$Bn) Trend Analysis By Market Taxonomy, 2017-2021

    17.4. Market Value (US$Bn) & Forecast By Market Taxonomy, 2022-2032

        17.4.1. By Country

            17.4.1.1. UAE

            17.4.1.2. South Africa

            17.4.1.3. Saudi Arabia

            17.4.1.4. Israel

            17.4.1.5. Rest of Middle East and Africa

        17.4.2. By Disease Type

        17.4.3. By Treatment Type

        17.4.4. By Sales Channel

        17.4.5. By Gender

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Disease Type

        17.5.3. By Treatment Type

        17.5.4. By Sales Channel

        17.5.5. By Gender

18. Key Countries Market Analysis 2017-2021 and Forecast 2022-2032

    18.1. Introduction

        18.1.1. Market Value Proportion Analysis, By Key Countries

        18.1.2. Global Vs. Country Growth Comparison

    18.2. US Market Analysis

        18.2.1. Value Proportion Analysis by Market Taxonomy

        18.2.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.2.2.1. By Disease Type

            18.2.2.2. By Treatment Type

            18.2.2.3. By Sales Channel

            18.2.2.4. By Gender

    18.3. Canada Market Analysis

        18.3.1. Value Proportion Analysis by Market Taxonomy

        18.3.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.3.2.1. By Disease Type

            18.3.2.2. By Treatment Type

            18.3.2.3. By Sales Channel

            18.3.2.4. By Gender

    18.4. Mexico Market Analysis

        18.4.1. Value Proportion Analysis by Market Taxonomy

        18.4.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.4.2.1. By Disease Type

            18.4.2.2. By Treatment Type

            18.4.2.3. By Sales Channel

            18.4.2.4. By Gender

    18.5. Brazil Market Analysis

        18.5.1. Value Proportion Analysis by Market Taxonomy

        18.5.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.5.2.1. By Disease Type

            18.5.2.2. By Treatment Type

            18.5.2.3. By Sales Channel

            18.5.2.4. By Gender

    18.6. Germany Market Analysis

        18.6.1. Value Proportion Analysis by Market Taxonomy

        18.6.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.6.2.1. By Disease Type

            18.6.2.2. By Treatment Type

            18.6.2.3. By Sales Channel

            18.6.2.4. By Gender

    18.7. France Market Analysis

        18.7.1. Value Proportion Analysis by Market Taxonomy

        18.7.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.7.2.1. By Disease Type

            18.7.2.2. By Treatment Type

            18.7.2.3. By Sales Channel

            18.7.2.4. By Gender

    18.8. Italy Market Analysis

        18.8.1. Value Proportion Analysis by Market Taxonomy

        18.8.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.8.2.1. By Disease Type

            18.8.2.2. By Treatment Type

            18.8.2.3. By Sales Channel

            18.8.2.4. By Gender

    18.9. Spain Market Analysis

        18.9.1. Value Proportion Analysis by Market Taxonomy

        18.9.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.9.2.1. By Disease Type

            18.9.2.2. By Treatment Type

            18.9.2.3. By Sales Channel

            18.9.2.4. By Gender

    18.10. UK Market Analysis

        18.10.1. Value Proportion Analysis by Market Taxonomy

        18.10.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.10.2.1. By Disease Type

            18.10.2.2. By Treatment Type

            18.10.2.3. By Sales Channel

            18.10.2.4. By Gender

    18.11. Russia Market Analysis

        18.11.1. Value Proportion Analysis by Market Taxonomy

        18.11.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.11.2.1. By Disease Type

            18.11.2.2. By Treatment Type

            18.11.2.3. By Sales Channel

            18.11.2.4. By Gender

    18.12. China Market Analysis

        18.12.1. Value Proportion Analysis by Market Taxonomy

        18.12.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.12.2.1. By Disease Type

            18.12.2.2. By Treatment Type

            18.12.2.3. By Sales Channel

            18.12.2.4. By Gender

    18.13. Japan Market Analysis

        18.13.1. Value Proportion Analysis by Market Taxonomy

        18.13.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.13.2.1. By Disease Type

            18.13.2.2. By Treatment Type

            18.13.2.3. By Sales Channel

            18.13.2.4. By Gender

    18.14. South Korea Market Analysis

        18.14.1. Value Proportion Analysis by Market Taxonomy

        18.14.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.14.2.1. By Disease Type

            18.14.2.2. By Treatment Type

            18.14.2.3. By Sales Channel

            18.14.2.4. By Gender

    18.15. UAE Market Analysis

        18.15.1. Value Proportion Analysis by Market Taxonomy

        18.15.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.15.2.1. By Disease Type

            18.15.2.2. By Treatment Type

            18.15.2.3. By Sales Channel

            18.15.2.4. By Gender

    18.16. South Africa Market Analysis

        18.16.1. Value Proportion Analysis by Market Taxonomy

        18.16.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.16.2.1. By Disease Type

            18.16.2.2. By Treatment Type

            18.16.2.3. By Sales Channel

            18.16.2.4. By Gender

    18.17. Saudi Arabia Market Analysis

        18.17.1. Value Proportion Analysis by Market Taxonomy

        18.17.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032

            18.17.2.1. By Disease Type

            18.17.2.2. By Treatment Type

            18.17.2.3. By Sales Channel

            18.17.2.4. By Gender

        18.17.3. Competition Landscape and Player Concentration in the Country

19. Market Structure Analysis

    19.1. Market Analysis by Tier of Companies

    19.2. Market Concentration

    19.3. Market Share Analysis of Top Players

    19.4. Market Presence Analysis

        19.4.1. By Regional footprint of Players

        19.4.2. Product footprint by Players

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep Dive

        20.3.1. iRestore Hair Growth System

            20.3.1.1. Overview

            20.3.1.2. Product Portfolio

            20.3.1.3. Sales Footprint

            20.3.1.4. Strategy Overview

        20.3.2. iGrow Laser

            20.3.2.1. Overview

            20.3.2.2. Product Portfolio

            20.3.2.3. Sales Footprint

            20.3.2.4. Strategy Overview

        20.3.3. Theradome

            20.3.3.1. Overview

            20.3.3.2. Product Portfolio

            20.3.3.3. Sales Footprint

            20.3.3.4. Strategy Overview

        20.3.4. Curallux

            20.3.4.1. Overview

            20.3.4.2. Product Portfolio

            20.3.4.3. Sales Footprint

            20.3.4.4. Strategy Overview

        20.3.5. LLC

            20.3.5.1. Overview

            20.3.5.2. Product Portfolio

            20.3.5.3. Sales Footprint

            20.3.5.4. Strategy Overview

        20.3.6. LUTRONIC

            20.3.6.1. Overview

            20.3.6.2. Product Portfolio

            20.3.6.3. Sales Footprint

            20.3.6.4. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$Bn),By Disease Type , 2017 – 2021

Table 2: Global Market Value (US$Bn),By Disease Type , 2022 – 2032

Table 3: Global Market Value (US$Bn), By Treatment Type , 2017 – 2021

Table 4: Global Market Value (US$Bn), By Treatment Type , 2022 – 2032

Table 5: Global Market Value (US$Bn), By Gender , 2017 – 2021

Table 6: Global Market Value (US$Bn), By Gender , 2022 – 2032

Table 7: Global Market Value (US$Bn), By Sales Channel , 2017 – 2021

Table 8: Global Market Value (US$Bn), By Sales Channel , 2022 – 2032

Table 9: Global Market, By Region, 2017 – 2021

Table 10: Global Market, By Region, 2022 – 2032

Table 11: North America Market Value (US$Bn),By Disease Type , 2017 – 2021

Table 12: North America Market Value (US$Bn),By Disease Type , 2022 – 2032

Table 13: North America Market Value (US$Bn), By Treatment Type , 2017 – 2021

Table 14: North America Market Value (US$Bn), By Treatment Type , 2022 – 2032

Table 15: North America Market Value (US$Bn), By Gender , 2017 – 2021

Table 16: North America Market Value (US$Bn), By Gender , 2022 – 2032

Table 17: North America Market Value (US$Bn), By Sales Channel , 2017 – 2021

Table 18: North America Market Value (US$Bn), By Sales Channel , 2022 – 2032

Table 19: North America Market, By Country, 2017 – 2021

Table 20: North America Market, By Country, 2022 – 2032

Table 21: Latin America Market Value (US$Bn),By Disease Type , 2017 – 2021

Table 22: Latin America Market Value (US$Bn),By Disease Type , 2022 – 2032

Table 23: Latin America Market Value (US$Bn), By Treatment Type , 2017 – 2021

Table 24: Latin America Market Value (US$Bn), By Treatment Type , 2022 – 2032

Table 25: Latin America Market Value (US$Bn), By Gender , 2017 – 2021

Table 26: Latin America Market Value (US$Bn), By Gender , 2022 – 2032

Table 27: Latin America Market Value (US$Bn), By Sales Channel , 2017 – 2021

Table 28: Latin America Market Value (US$Bn), By Sales Channel , 2022 – 2032

Table 29: Latin America Market, By Country, 2017 – 2021

Table 30: Latin America Market, By Country, 2022 – 2032

Table 31: Europe Market Value (US$Bn),By Disease Type , 2017 – 2021

Table 32: Europe Market Value (US$Bn),By Disease Type , 2022 – 2032

Table 33: Europe Market Value (US$Bn), By Treatment Type , 2017 – 2021

Table 34: Europe Market Value (US$Bn), By Treatment Type , 2022 – 2032

Table 35: Europe Market Value (US$Bn), By Gender , 2017 – 2021

Table 36: Europe Market Value (US$Bn), By Gender , 2022 – 2032

Table 37: Europe Market Value (US$Bn), By Sales Channel , 2017 – 2021

Table 38: Europe Market Value (US$Bn), By Sales Channel , 2022 – 2032

Table 39: Europe Market, By Country, 2017 – 2021

Table 40: Europe Market, By Country, 2022 – 2032

Table 41: Asia Pacific Market Value (US$Bn),By Disease Type , 2017 – 2021

Table 42: Asia Pacific Market Value (US$Bn),By Disease Type , 2022 – 2032

Table 43: Asia Pacific Market Value (US$Bn), By Treatment Type , 2017 – 2021

Table 44: Asia Pacific Market Value (US$Bn), By Treatment Type , 2022 – 2032

Table 45: Asia Pacific Market Value (US$Bn), By Gender , 2017 – 2021

Table 46: Asia Pacific Market Value (US$Bn), By Gender , 2022 – 2032

Table 47: Asia Pacific Market Value (US$Bn), By Sales Channel , 2017 – 2021

Table 48: Asia Pacific Market Value (US$Bn), By Sales Channel , 2022 – 2032

Table 49: Asia Pacific Market, By Country, 2017 – 2021

Table 50: Asia Pacific Market, By Country, 2022 – 2032

Table 51: MEA Market Value (US$Bn),By Disease Type , 2017 – 2021

Table 52: MEA Market Value (US$Bn),By Disease Type , 2022 – 2032

Table 53: MEA Market Value (US$Bn), By Treatment Type , 2017 – 2021

Table 54: MEA Market Value (US$Bn), By Treatment Type , 2022 – 2032

Table 55: MEA Market Value (US$Bn), By Gender , 2017 – 2021

Table 56: MEA Market Value (US$Bn), By Gender , 2022 – 2032

Table 57: MEA Market Value (US$Bn), By Sales Channel , 2017 – 2021

Table 58: MEA Market Value (US$Bn), By Sales Channel , 2022 – 2032

Table 59: MEA Market, By Country, 2017 – 2021

Table 60: MEA Market, By Country, 2022 – 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$Bn) and Year-on-Year Growth, 2017-2032

Figure 2: Global Market Absolute $ Historical Gain (2017 - 2021) and Opportunity (2022 – 2032), US$Bn

Figure 3: Global Market Share, By Disease Type , 2022 & 2032

Figure 4: Global Market Y-o-Y Growth Projections, By Disease Type – 2022-2032

Figure 5: Global Market Attractiveness Index, By Disease Type – 2022-2032

Figure 6: Global Market Share, By Treatment Type , 2022 & 2032

Figure 7: Global Market Y-o-Y Growth Projections, By Treatment Type – 2022-2032

Figure 8: Global Market Attractiveness Index, By Treatment Type – 2022-2032

Figure 9: Global Market Share, By Sales Channel , 2022 & 2032

Figure 10: Global Market Y-o-Y Growth Projections, By Sales Channel – 2022-2032

Figure 11: Global Market Attractiveness Index, By Sales Channel – 2022-2032

Figure 12: Global Market Share, By Gender , 2022 & 2032

Figure 13: Global Market Y-o-Y Growth Projections, By Gender – 2022-2032

Figure 14: Global Market Attractiveness Index, By Gender – 2022-2032

Figure 15: Global Market Share, By Region, 2022 & 2032

Figure 16: Global Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 17: Global Market Attractiveness Index, By Region – 2022-2032

Figure 18: North America Market Value (US$Bn) and Year-on-Year Growth, 2017-2032

Figure 19: North America Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$Bn

Figure 20: North America Market Share, By Disease Type , 2022 & 2032

Figure 21: North America Market Y-o-Y Growth Projections, By Disease Type – 2022-2032

Figure 22: North America Market Attractiveness Index, By Disease Type – 2022-2032

Figure 23: North America Market Share, By Treatment Type , 2022 & 2032

Figure 24: North America Market Y-o-Y Growth Projections, By Treatment Type – 2022-2032

Figure 25: North America Market Attractiveness Index, By Treatment Type – 2022-2032

Figure 26: North America Market Share, By Sales Channel , 2022 & 2032

Figure 27: North America Market Y-o-Y Growth Projections, By Sales Channel – 2022-2032

Figure 28: North America Market Attractiveness Index, By Sales Channel – 2022-2032

Figure 29: North America Market Share, By Gender , 2022 & 2032

Figure 30: North America Market Y-o-Y Growth Projections, By Gender – 2022-2032

Figure 31: North America Market Attractiveness Index, By Gender – 2022-2032

Figure 32: North America Market Share, By Country, 2022 & 2032

Figure 33: North America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 34: North America Market Attractiveness Index, By Country – 2022-2032

Figure 35: Latin America Market Value (US$Bn) and Year-on-Year Growth, 2017-2032

Figure 36: Latin America Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$Bn

Figure 37: Latin America Market Share, By Disease Type , 2022 & 2032

Figure 38: Latin America Market Y-o-Y Growth Projections, By Disease Type – 2022-2032

Figure 39: Latin America Market Attractiveness Index, By Disease Type – 2022-2032

Figure 40: Latin America Market Share, By Treatment Type , 2022 & 2032

Figure 41: Latin America Market Y-o-Y Growth Projections, By Treatment Type – 2022-2032

Figure 42: Latin America Market Attractiveness Index, By Treatment Type – 2022-2032

Figure 43: Latin America Market Share, By Sales Channel , 2022 & 2032

Figure 44: Latin America Market Y-o-Y Growth Projections, By Sales Channel – 2022-2032

Figure 45: Latin America Market Attractiveness Index, By Sales Channel – 2022-2032

Figure 46: Latin America Market Share, By Gender , 2022 & 2032

Figure 47: Latin America Market Y-o-Y Growth Projections, By Gender – 2022-2032

Figure 48: Latin America Market Attractiveness Index, By Gender – 2022-2032

Figure 49: Latin America Market Share, By Country, 2022 & 2032

Figure 50: Latin America Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 51: Latin America Market Attractiveness Index, By Country – 2022-2032

Figure 52: Europe Market Value (US$Bn) and Year-on-Year Growth, 2017-2032

Figure 53: Europe Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$Bn

Figure 54: Europe Market Share, By Disease Type , 2022 & 2032

Figure 55: Europe Market Y-o-Y Growth Projections, By Disease Type – 2022-2032

Figure 56: Europe Market Attractiveness Index, By Disease Type – 2022-2032

Figure 57: Europe Market Share, By Treatment Type , 2022 & 2032

Figure 58: Europe Market Y-o-Y Growth Projections, By Treatment Type – 2022-2032

Figure 59: Europe Market Attractiveness Index, By Treatment Type – 2022-2032

Figure 60: Europe Market Share, By Sales Channel , 2022 & 2032

Figure 61: Europe Market Y-o-Y Growth Projections, By Sales Channel – 2022-2032

Figure 62: Europe Market Attractiveness Index, By Sales Channel – 2022-2032

Figure 63: Europe Market Share, By Gender , 2022 & 2032

Figure 64: Europe Market Y-o-Y Growth Projections, By Gender – 2022-2032

Figure 65: Europe Market Attractiveness Index, By Gender – 2022-2032

Figure 66: Europe Market Share, By Country, 2022 & 2032

Figure 67: Europe Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 68: Europe Market Attractiveness Index, By Country – 2022-2032

Figure 69: MEA Market Value (US$Bn) and Year-on-Year Growth, 2017-2032

Figure 70: MEA Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$Bn

Figure 71: MEA Market Share, By Disease Type , 2022 & 2032

Figure 72: MEA Market Y-o-Y Growth Projections, By Disease Type – 2022-2032

Figure 73: MEA Market Attractiveness Index, By Disease Type – 2022-2032

Figure 74: MEA Market Share, By Treatment Type , 2022 & 2032

Figure 75: MEA Market Y-o-Y Growth Projections, By Treatment Type – 2022-2032

Figure 76: MEA Market Attractiveness Index, By Treatment Type – 2022-2032

Figure 77: MEA Market Share, By Sales Channel , 2022 & 2032

Figure 78: MEA Market Y-o-Y Growth Projections, By Sales Channel – 2022-2032

Figure 79: MEA Market Attractiveness Index, By Sales Channel – 2022-2032

Figure 80: MEA Market Share, By Gender , 2022 & 2032

Figure 81: MEA Market Y-o-Y Growth Projections, By Gender – 2022-2032

Figure 82: MEA Market Attractiveness Index, By Gender – 2022-2032

Figure 83: MEA Market Share, By Country, 2022 & 2032

Figure 84: MEA Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 85: MEA Market Attractiveness Index, By Country – 2022-2032

Figure 86: Asia Pacific Market Value (US$Bn) and Year-on-Year Growth, 2017-2032

Figure 87: Asia Pacific Market Absolute $ Opportunity Historical (2017 - 2021) and Forecast Period (2022 – 2032), US$Bn

Figure 88: Asia Pacific Market Share, By Disease Type , 2022 & 2032

Figure 89: Asia Pacific Market Y-o-Y Growth Projections, By Disease Type – 2022-2032

Figure 90: Asia Pacific Market Attractiveness Index, By Disease Type – 2022-2032

Figure 91: Asia Pacific Market Share, By Treatment Type , 2022 & 2032

Figure 92: Asia Pacific Market Y-o-Y Growth Projections, By Treatment Type – 2022-2032

Figure 93: Asia Pacific Market Attractiveness Index, By Treatment Type – 2022-2032

Figure 94: Asia Pacific Market Share, By Sales Channel , 2022 & 2032

Figure 95: Asia Pacific Market Y-o-Y Growth Projections, By Sales Channel – 2022-2032

Figure 96: Asia Pacific Market Attractiveness Index, By Sales Channel – 2022-2032

Figure 97: Asia Pacific Market Share, By Gender , 2022 & 2032

Figure 98: Asia Pacific Market Y-o-Y Growth Projections, By Gender – 2022-2032

Figure 99: Asia Pacific Market Attractiveness Index, By Gender – 2022-2032

Figure 100: Asia Pacific Market Share, By Country, 2022 & 2032

Figure 101: Asia Pacific Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 102: Asia Pacific Market Attractiveness Index, By Country – 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Alopecia Treatment Market